Nashville, Tennessee
Alzheimer's disease clinical trials in Nashville, TN
10 Alzheimer's disease studies are recruiting participants at sites in Nashville as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Nashville at a glance
- 10 studies are recruiting at a site in Nashville.
- By phase: Phase 2 (5), Phase 3 (2), Observational (3).
- By sponsor: industry (5), university, hospital or other (5).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Nashville
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- K2 Medical Research - Nashville
- Registry record
- NCT07177352 · updated
Tennessee Alzheimer's Project
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Vanderbilt University Medical Center
- Study site
- Vanderbilt University Medical Center
- Registry record
- NCT05372172 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Vanderbilt Psychiatric Hospital
- Registry record
- NCT06585787 · updated
Alzheimer's Tau Platform: Master Protocol
- Phase 2
- Ages 50 to 80
- All sexes
- Sponsor
- Paul S. Aisen
- Study site
- Vanderbilt University Medical Center
- Registry record
- NCT06957418 · updated
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Phase 2
- Ages 55 to 80
- All sexes
- Sponsor
- Lighthouse Pharmaceuticals, Inc.
- Study site
- K2 Medical Research Nashville LLC
- Registry record
- NCT06847321 · updated
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- Celgene
- Study site
- Vanderbilt University Medical Center- Village
- Registry record
- NCT06808984 · updated
Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- NewAmsterdam Pharma
- Study site
- K2 Medical Research
- Registry record
- NCT07794670 · updated
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
- Phase 2
- Ages 18 to 55
- All sexes
- Sponsor
- Vanderbilt University Medical Center
- Study site
- Vanderbilt University Medical Center Clinical Research Center
- Registry record
- NCT05231798 · updated
Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Observational
- Ages 25 to 55
- All sexes
- Sponsor
- University of Southern California
- Study site
- Vanderbilt University Medical Center Center for Cognitive Medicine
- Registry record
- NCT04165109 · updated
Swallowing Impairments in Adults With and Without Alzheimer's Disease
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Vanderbilt University Medical Center
- Study site
- Vanderbilt University Medical Center
- Registry record
- NCT06678100 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Nashville, TN on ClinicalTrials.gov.
Ask about studies near Nashville
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections